Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics



Rating:

Share or cite this content

Citations should be made in the following way:
A. Szpechcinski, K. Maszkowska-Kopij, W. Kupis, J. Zaleska, E. Radzikowska, R. Struniawski, E. Puscinska, T. Orlowski, P. Sliwinski, K. Roszkowski-Sliz, J. Chorostowska-Wynimko (Warsaw, Poland). The clinical significance of plasma DNA quantification in NSCLC. Eur Respir J 2011; 38: Suppl. 55, 1954

Member's Comments

No comment yet.

Related content which might interest you: The detection of quantitative serum p53 protein in lung cancer and its clinical value Source: Eur Respir J 2003; 22: Suppl. 45, 363s Year: 2003 Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 The predictive value of total vs. amplificable free-circulating DNA in plasma of NSCLC patients – a preliminary study Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 Clinical evaluation of the plasma levels of hTERT and EGFR expression as markers for early detection of non-small cell lung cancer Source: Annual Congress 2009 - Basic science and lung cancer Year: 2009 Free plasmatic circulating DNA as prognostic and diagnostic lung cancer biomarker Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 Real-time PCR analysis of free-circulating DNA in plasma of non-small cell lung cancer patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Circulating free DNA concentration is an independent prognostic biomarker in lung cancer Source: Eur Respir J 2015; 46: 1773-1780 Year: 2015 Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer Source: Eur Respir J 2010; 36: 885-892 Year: 2010 The clinical significance of soluble E-cadherin in lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 769s Year: 2006 Prognostic significance of plasma D-dimer (DD) in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002 Quantitative methylation profiles of multiple genes in patients with non-small cell lung cancer and its association with clinicopathological correlations Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 PTGER4, a promising novel DNA methylation marker for lung cancer measured in a clinical case control study using blood plasma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Plasma DNA concentration and integrity measurement for NSCLC diagnostics and radical therapy effectiveness monitoring Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Clinical significance of serum cathepsin K level during chemotherapy of lung cancer. Can we use it as a marker of small cell lung cancer? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Clinical significance of serum osteopontin levels in lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Small cell lung cancer: prognostic significance and correlation with clinical and laboratory parameters Source: Eur Respir J 2007; 30: Suppl. 51, 670s Year: 2007 The predictive value of circulating tumor DNA dynamics in plasma of EGFR-mutation-positive NSCLC patients on first line tyrosine kinase inhibitors Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 The clinical significance of plasma and urine lysophospholipids-producing enzymes in patients with sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Hypermethylation pattern in genomic DNA samples derived from tumor and serum of resected non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Clinical significance of serum adipokines levels in lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009